Climb Bio, Inc. (CLYM) Form 424B3 — Jun 9, 2026
Climb Bio, Inc. filed a prospectus supplement to register the resale of 11,587,000 shares of common stock held by selling stockholders. These shares were originally issued in a private placement in April 2026 that raised approximately $110 million for the company. The company will not receive any proceeds from the resale of these shares by the selling stockholders.
Key figures
- Gross Proceeds
- 0
- Shares Offered
- 11587000
- Last Closing Price
- 10.77
- Shares Outstanding
- 57263023
- Prefunded Warrant Price
- 9.4999
- Prefunded Warrants Issued
- 2106000
- Prefunded Warrant Exercise Price
- 0.0001
- Private Placement Gross Proceeds
- 110000000
- Private Placement Price Per Share
- 9.5
- Shares Issued In Private Placement
- 9481000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.